Jo Robson Jo.Robson@uwe.ac.uk
Consultant Associate Professor in Rheumatology
Assessing glucocorticoid toxicity: Are the measures sensitive enough?
Robson, Joanna C; Dawson, Jill; Ndosi, Mwidimi
Authors
Jill Dawson
Dr Mwidimi Ndosi Mwidimi.Ndosi@uwe.ac.uk
Associate Professor in Nursing Rheumatology
Abstract
The Glucocorticoid Toxicity Index (GTI) is a composite instrument designed to capture change in glucocorticoid-related morbidity over time.1 It was developed through consensus methods and multi-
criteria decisions among 19 medical specialists, with relative domain weights decided via clinician consensus.2 The GTI has now been used in more than 45 studies, including 12 phase 3 clinical trials.1
The GTI comprises eight domains: body mass index, blood pressure, glucose tolerance, lipid metabolism, glucocorticoid myopathy, skin toxicity, neuropsychiatric effects and infections. Two overall scores are calculated: the cumulative worsening score (CWS), which includes transient and permanent GC toxicity from baseline to specific time points, and the Aggregate Improvement Score (AIS), which accounts for improvement as well as worsening GC-toxicity.1 In The Lancet Rheumatology, Naomi Patel and colleagues3 present an analysis of domain scores of the GTI using data from the phase 3 ADVOCATE trial.4 In a clinical trial context where the GTI is used to produce repeated measures to demonstrate differences between (and within) groups of patients taking different dosages of glucocorticoids, and to measure the impact of steroid sparing agents, it is expected to have a high level of measurement validity and reliability.
Journal Article Type | Article |
---|---|
Acceptance Date | Feb 3, 2023 |
Online Publication Date | Feb 20, 2023 |
Publication Date | Mar 31, 2023 |
Deposit Date | Feb 22, 2023 |
Publicly Available Date | Feb 22, 2023 |
Journal | The Lancet. Rheumatology |
Print ISSN | 2665-9913 |
Electronic ISSN | 2665-9913 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 5 |
Issue | 3 |
Pages | e113-e114 |
DOI | https://doi.org/10.1016/S2665-9913%2823%2900037-1 |
Keywords | Glucocorticoids - toxicity |
Public URL | https://uwe-repository.worktribe.com/output/10479713 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S2665991323000371 |
Files
Assessing glucocorticoid toxicity: are the measures sensitive enough?
(166 Kb)
PDF
Licence
http://creativecommons.org/licenses/by-nc-nd/4.0/
Publisher Licence URL
http://creativecommons.org/licenses/by-nc-nd/4.0/
Copyright Statement
This is the authors accepted version of the article ‘Robson, J. C., Dawson, J., & Ndosi, M. (2023). Assessing glucocorticoid toxicity: Are the measures sensitive enough?. The Lancet Rheumatology, 5(3), e113-e114’. DOI: https://doi.org/10.1016/S2665-9913%2823%2900037-1
The final published version is available here: https://www.sciencedirect.com/science/article/abs/pii/S2665991323000371?via%3Dihub
© 2023 Elsevier Ltd. All rights reserved.
You might also like
The OMERACT emerging leaders program: The good, the bad, and the future
(2019)
Journal Article
Update on outcome measure development in large-vessel vasculitis: Report from OMERACT 2018
(2019)
Journal Article
Downloadable Citations
About UWE Bristol Research Repository
Administrator e-mail: repository@uwe.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search